首页> 外文期刊>Journal of endocrinological investigation. >Association of benign thyroid diseases with thyroid cancer risk: a meta-analysis of prospective observational studies
【24h】

Association of benign thyroid diseases with thyroid cancer risk: a meta-analysis of prospective observational studies

机译:良性甲状腺疾病与甲状腺癌风险的关联:前瞻性观察研究的荟萃分析

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

PurposeEvidence showed that benign thyroid disease was one of the risk factors for thyroid cancer. However, the results of some studies were inconsistent and were previously meta-analyses of case-control studies. Therefore, we performed a meta-analysis of prospective studies to investigate the relationship between benign thyroid diseases and thyroid cancer risk.MethodsAll eligible studies were identified via systematic searches of multiple literature databases. The combined RR (relative risk)/HR (hazard ratio) or SIR (standardized incidence ratio) with 95 confidence interval was calculated. Heterogeneity was assessed with the I-2 test. Publication bias and subgroup analyses were also performed.ResultsTwelve studies were eligible for inclusion in the meta-analysis. The pooled RR/HR of thyroid carcinoma in benign thyroid diseases was 4.39 (95 CI 3.22-5.55). The pooled SIR of thyroid carcinoma in benign thyroid diseases was 5.98 (95 CI 4.09-7.86). Subgroup analysis was performed using the type of benign thyroid diseases. Effect value was RR/HR: hyperthyroidism (RR/HR=3.89, 95 CI=1.69-6.08), hypothyroidism (RR/HR=2.72, 95 CI=1.04-4.41), and goiter (RR/HR=22.18, 95 CI=12.09-32.28). Effect value was SIR: hyperthyroidism (RR/HR=5.96, 95 CI=1.88-10.03), goiter (RR/HR=7.65, 95 CI=6.94-8.37), and thyroiditis (RR/HR=3.25, 95 CI=1.62-4.89).ConclusionsOur study has shown that benign thyroid diseases might be associated with increased risk of thyroid cancer, especially in hyperthyroidism, hypothyroidism, and goiter. However, further investigation is needed to better understand the underlying biological mechanisms.
机译:目的证据显示,甲状腺良性疾病是甲状腺癌的危险因素之一。然而,一些研究的结果不一致,以前是病例对照研究的meta分析。因此,我们对前瞻性研究进行了荟萃分析,以调查良性甲状腺疾病与甲状腺癌风险之间的关系。方法通过系统检索多个文献数据库确定所有符合条件的研究。计算具有 95% 置信区间的 RR(相对风险)/HR(风险比)或 SIR(标准化发病率)的组合。使用 I-2 检验评估异质性。还进行了发表偏倚和亚组分析。结果12项研究符合纳入meta分析的条件。甲状腺良性疾病中甲状腺癌的合并RR/HR为4.39(95%CI 3.22-5.55)。甲状腺良性疾病中甲状腺癌的汇总SIR为5.98(95%CI 4.09-7.86)。使用良性甲状腺疾病的类型进行亚组分析。效应值为RR/HR:甲状腺功能亢进(RR/HR=3.89,95%CI=1.69-6.08)、甲状腺功能减退(RR/HR=2.72,95%CI=1.04-4.41)和甲状腺肿(RR/HR=22.18,95%CI=12.09-32.28)。效应值为SIR:甲状腺功能亢进(RR/HR=5.96,95%CI=1.88-10.03)、甲状腺肿(RR/HR=7.65,95%CI=6.94-8.37)、甲状腺炎(RR/HR=3.25,95%CI=1.62-4.89)。结论我们的研究表明,良性甲状腺疾病可能与甲状腺癌风险增加有关,尤其是甲状腺功能亢进症、甲状腺功能减退症和甲状腺肿。然而,需要进一步的研究来更好地了解潜在的生物学机制。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号